目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. TUBERCULOSIS THERAPEUTICS MARKET, BY TREATMENT TYPE (USD BILLION)
6.1. First-Line Therapies
6.2. Second-Line Therapies
6.3. Multidrug-Resistant Therapies
6.4. Extensively Drug-Resistant Therapies

7. TUBERCULOSIS THERAPEUTICS MARKET, BY DRUG CLASS (USD BILLION)
7.1. Quinolones
7.2. Rifamycins
7.3. Nitroimidazoles
7.4. Macrolides
7.5. Aminoglycosides

8. TUBERCULOSIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
8.1. Oral
8.2. Injectable
8.3. Intravenous

9. TUBERCULOSIS THERAPEUTICS MARKET, BY PATIENT POPULATION (USD BILLION)
9.1. Adults
9.2. Children
9.3. Pregnant Women

10. TUBERCULOSIS THERAPEUTICS MARKET, BY TUBERCULOSIS TYPE (USD BILLION)
10.1. Pulmonary
10.2. Extra-Pulmonary
10.3. Multidrug-Resistant

11. TUBERCULOSIS THERAPEUTICS MARKET, BY REGIONAL (USD BILLION)
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. UK
11.2.3. France
11.2.4. Russia
11.2.5. Italy
11.2.6. Spain
11.2.7. Rest of Europe
11.3. APAC
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Malaysia
11.3.6. Thailand
11.3.7. Indonesia
11.3.8. Rest of APAC
11.4. South America
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of South America
11.5. MEA
11.5.1. GCC Countries
11.5.2. South Africa
11.5.3. Rest of MEA

12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market share Analysis
12.4. Major Growth Strategy in the Tuberculosis Therapeutics Market
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Tuberculosis Therapeutics Market
12.7. Key developments and growth strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales and Operating Income
12.8.2. Major Players R&D Expenditure. 2023

13. COMPANY PROFILES
13.1. Mylan
13.1.1. Financial Overview
13.1.2. Products Offered
13.1.3. Key Developments
13.1.4. SWOT Analysis
13.1.5. Key Strategies
13.2. Pfizer
13.2.1. Financial Overview
13.2.2. Products Offered
13.2.3. Key Developments
13.2.4. SWOT Analysis
13.2.5. Key Strategies
13.3. GlaxoSmithKline
13.3.1. Financial Overview
13.3.2. Products Offered
13.3.3. Key Developments
13.3.4. SWOT Analysis
13.3.5. Key Strategies
13.4. Cipla
13.4.1. Financial Overview
13.4.2. Products Offered
13.4.3. Key Developments
13.4.4. SWOT Analysis
13.4.5. Key Strategies
13.5. Merck Co
13.5.1. Financial Overview
13.5.2. Products Offered
13.5.3. Key Developments
13.5.4. SWOT Analysis
13.5.5. Key Strategies
13.6. Boehringer Ingelheim
13.6.1. Financial Overview
13.6.2. Products Offered
13.6.3. Key Developments
13.6.4. SWOT Analysis
13.6.5. Key Strategies
13.7. AstraZeneca
13.7.1. Financial Overview
13.7.2. Products Offered
13.7.3. Key Developments
13.7.4. SWOT Analysis
13.7.5. Key Strategies
13.8. Abbott Laboratories
13.8.1. Financial Overview
13.8.2. Products Offered
13.8.3. Key Developments
13.8.4. SWOT Analysis
13.8.5. Key Strategies
13.9. Lupin
13.9.1. Financial Overview
13.9.2. Products Offered
13.9.3. Key Developments
13.9.4. SWOT Analysis
13.9.5. Key Strategies
13.10. Teva Pharmaceutical Industries
13.10.1. Financial Overview
13.10.2. Products Offered
13.10.3. Key Developments
13.10.4. SWOT Analysis
13.10.5. Key Strategies
13.11. Alkermes
13.11.1. Financial Overview
13.11.2. Products Offered
13.11.3. Key Developments
13.11.4. SWOT Analysis
13.11.5. Key Strategies
13.12. Novartis
13.12.1. Financial Overview
13.12.2. Products Offered
13.12.3. Key Developments
13.12.4. SWOT Analysis
13.12.5. Key Strategies
13.13. Johnson Johnson
13.13.1. Financial Overview
13.13.2. Products Offered
13.13.3. Key Developments
13.13.4. SWOT Analysis
13.13.5. Key Strategies
13.14. Sanofi
13.14.1. Financial Overview
13.14.2. Products Offered
13.14.3. Key Developments
13.14.4. SWOT Analysis
13.14.5. Key Strategies
13.15. Otsuka Pharmaceutical
13.15.1. Financial Overview
13.15.2. Products Offered
13.15.3. Key Developments
13.15.4. SWOT Analysis
13.15.5. Key Strategies

14. APPENDIX
14.1. References
14.2. Related Reports

LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 7. NORTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 8. US TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 9. US TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 10. US TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 11. US TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 12. US TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. US TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 17. CANADA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 18. CANADA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 19. CANADA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 22. EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 23. EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 24. EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 25. EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 27. GERMANY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 28. GERMANY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 29. GERMANY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 30. GERMANY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 31. GERMANY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. UK TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. UK TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 34. UK TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 35. UK TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 36. UK TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 37. UK TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 38. FRANCE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 39. FRANCE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 40. FRANCE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 41. FRANCE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 42. FRANCE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. FRANCE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 44. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 45. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 46. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 47. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 48. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 49. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 50. ITALY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 51. ITALY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 52. ITALY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 53. ITALY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 54. ITALY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 55. ITALY TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 56. SPAIN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 57. SPAIN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 58. SPAIN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 59. SPAIN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 60. SPAIN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 61. SPAIN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 64. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 65. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 66. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 67. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 68. APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 69. APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 70. APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 71. APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 72. APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 74. CHINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 75. CHINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 76. CHINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 77. CHINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 78. CHINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 79. CHINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 80. INDIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 81. INDIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 82. INDIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 83. INDIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 84. INDIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 85. INDIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 86. JAPAN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 87. JAPAN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 88. JAPAN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 89. JAPAN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 90. JAPAN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 91. JAPAN TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 94. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 95. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 96. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 97. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 98. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 99. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 100. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 101. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 102. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 104. THAILAND TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 105. THAILAND TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 106. THAILAND TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 107. THAILAND TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 108. THAILAND TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 109. THAILAND TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 110. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 111. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 112. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 113. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 114. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 115. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 116. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 117. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 118. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 119. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 120. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 121. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 124. SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 125. SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 126. SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 127. SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 128. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 129. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 130. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 131. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 132. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 134. MEXICO TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 135. MEXICO TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 136. MEXICO TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 137. MEXICO TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 138. MEXICO TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 139. MEXICO TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 140. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 141. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 142. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 143. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 144. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 145. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 147. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 148. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 149. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 150. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 151. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 152. MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 153. MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 154. MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 155. MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 156. MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 157. MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 158. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 159. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 160. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 161. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 162. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 163. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 164. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 165. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 166. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 167. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 168. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 169. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 170. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 171. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 172. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 173. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT POPULATION, 2019-2032 (USD BILLIONS)
TABLE 174. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY TUBERCULOSIS TYPE, 2019-2032 (USD BILLIONS)
TABLE 175. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 176. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 177. ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS
FIGURE 3. US TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 4. US TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 5. US TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 6. US TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 7. US TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 8. US TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 9. CANADA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 10. CANADA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 11. CANADA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 12. CANADA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 13. CANADA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 14. CANADA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 15. EUROPE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS
FIGURE 16. GERMANY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 17. GERMANY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 18. GERMANY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 19. GERMANY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 20. GERMANY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 21. GERMANY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 22. UK TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 23. UK TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 24. UK TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 25. UK TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 26. UK TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 27. UK TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 28. FRANCE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 29. FRANCE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 30. FRANCE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 31. FRANCE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 32. FRANCE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 33. FRANCE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 34. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 35. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 36. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 37. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 38. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 39. RUSSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 40. ITALY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 41. ITALY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 42. ITALY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 43. ITALY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 44. ITALY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 45. ITALY TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 46. SPAIN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 47. SPAIN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 48. SPAIN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 49. SPAIN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 50. SPAIN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 51. SPAIN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 52. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 53. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 54. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 55. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 56. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 57. REST OF EUROPE TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 58. APAC TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS
FIGURE 59. CHINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 60. CHINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 61. CHINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 62. CHINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 63. CHINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 64. CHINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 65. INDIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 66. INDIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 67. INDIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 68. INDIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 69. INDIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 70. INDIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 71. JAPAN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 72. JAPAN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 73. JAPAN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 74. JAPAN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 75. JAPAN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 76. JAPAN TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 77. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 78. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 79. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 80. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 81. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 82. SOUTH KOREA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 83. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 84. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 85. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 86. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 87. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 88. MALAYSIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 89. THAILAND TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 90. THAILAND TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 91. THAILAND TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 92. THAILAND TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 93. THAILAND TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 94. THAILAND TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 95. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 96. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 97. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 98. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 99. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 100. INDONESIA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 101. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 102. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 103. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 104. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 105. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 106. REST OF APAC TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 107. SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS
FIGURE 108. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 109. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 110. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 111. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 112. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 113. BRAZIL TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 114. MEXICO TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 115. MEXICO TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 116. MEXICO TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 117. MEXICO TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 118. MEXICO TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 119. MEXICO TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 120. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 121. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 122. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 123. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 124. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 125. ARGENTINA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 126. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 127. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 128. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 129. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 130. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 131. REST OF SOUTH AMERICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 132. MEA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS
FIGURE 133. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 134. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 135. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 136. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 137. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 138. GCC COUNTRIES TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 139. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 140. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 141. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 142. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 143. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 144. SOUTH AFRICA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 145. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 146. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 147. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 148. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY PATIENT POPULATION
FIGURE 149. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY TUBERCULOSIS TYPE
FIGURE 150. REST OF MEA TUBERCULOSIS THERAPEUTICS MARKET ANALYSIS BY REGIONAL
FIGURE 151. KEY BUYING CRITERIA OF TUBERCULOSIS THERAPEUTICS MARKET
FIGURE 152. RESEARCH PROCESS OF MRFR
FIGURE 153. DRO ANALYSIS OF TUBERCULOSIS THERAPEUTICS MARKET
FIGURE 154. DRIVERS IMPACT ANALYSIS: TUBERCULOSIS THERAPEUTICS MARKET
FIGURE 155. RESTRAINTS IMPACT ANALYSIS: TUBERCULOSIS THERAPEUTICS MARKET
FIGURE 156. SUPPLY / VALUE CHAIN: TUBERCULOSIS THERAPEUTICS MARKET
FIGURE 157. TUBERCULOSIS THERAPEUTICS MARKET, BY TREATMENT TYPE, 2024 (% SHARE)
FIGURE 158. TUBERCULOSIS THERAPEUTICS MARKET, BY TREATMENT TYPE, 2019 TO 2032 (USD Billions)
FIGURE 159. TUBERCULOSIS THERAPEUTICS MARKET, BY DRUG CLASS, 2024 (% SHARE)
FIGURE 160. TUBERCULOSIS THERAPEUTICS MARKET, BY DRUG CLASS, 2019 TO 2032 (USD Billions)
FIGURE 161. TUBERCULOSIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 162. TUBERCULOSIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2032 (USD Billions)
FIGURE 163. TUBERCULOSIS THERAPEUTICS MARKET, BY PATIENT POPULATION, 2024 (% SHARE)
FIGURE 164. TUBERCULOSIS THERAPEUTICS MARKET, BY PATIENT POPULATION, 2019 TO 2032 (USD Billions)
FIGURE 165. TUBERCULOSIS THERAPEUTICS MARKET, BY TUBERCULOSIS TYPE, 2024 (% SHARE)
FIGURE 166. TUBERCULOSIS THERAPEUTICS MARKET, BY TUBERCULOSIS TYPE, 2019 TO 2032 (USD Billions)
FIGURE 167. TUBERCULOSIS THERAPEUTICS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 168. TUBERCULOSIS THERAPEUTICS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 169. BENCHMARKING OF MAJOR COMPETITORS